Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

COUNCIL ON PHYSICAL MEDICINE AND REHABILITATION

COUNCIL ON PHYSICAL MEDICINE AND REHABILITATION other four or five times seldom smaller doses are than for is Should esthesia, required gen¬ daily required. anesthetics. sensitization eral The same that are effective after further antagonists appear repeated applications, will should tubocurarine the action of use be discontinued. against interrupt galla¬ mine. 0.5 to 1.5 is mg., Neostigmine methylsulfate, mg. & French scientific Smith, Kline Laboratories by cooperated furnishing data to aid in evaluation of adminis¬ the hydrochloride. a useful antidote and sulfate be dimethisoquin atropine may the tered to counteract simultaneously postganglionic is effect of A dose of the antidote neostigmine. larger needed when is used in with ether gallamine conjunction the removal Anti¬ because latter of the impedes drug. COUNCIL ON PHYSICAL MEDICINE dotes should be used with caution in asthmatic patients AND REHABILITATION sensitive such Such adverse antidotal effect is to drugs. also counteracted with atropine. Laboratories co¬ Lederle Division, American Company, Cyanamid The Council on Medicine and Rehabilitation scientific data in the of Physical operated by to aid evaluation gallamine furnishing triethiodide. has authorized the article. of publication following De Ralph E. Forest, M.D., Secretary C17H24N2O.HCI. Dimethisoquin Hydrochloride. —M.W. 308.86.—3-Butyl-l-(2-dimethylaminoethoxy) FEDERAL COMMUNICATIONS COMMISSION structural formula of isoquinoline hydrochloride.—The TYPE APPROVAL FOR MEDICAL http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

COUNCIL ON PHYSICAL MEDICINE AND REHABILITATION

JAMA , Volume 159 (2) – Sep 10, 1955

Loading next page...
 
/lp/american-medical-association/council-on-physical-medicine-and-rehabilitation-40e4fH9yXt

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1955 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1955.02960190020008
Publisher site
See Article on Publisher Site

Abstract

other four or five times seldom smaller doses are than for is Should esthesia, required gen¬ daily required. anesthetics. sensitization eral The same that are effective after further antagonists appear repeated applications, will should tubocurarine the action of use be discontinued. against interrupt galla¬ mine. 0.5 to 1.5 is mg., Neostigmine methylsulfate, mg. & French scientific Smith, Kline Laboratories by cooperated furnishing data to aid in evaluation of adminis¬ the hydrochloride. a useful antidote and sulfate be dimethisoquin atropine may the tered to counteract simultaneously postganglionic is effect of A dose of the antidote neostigmine. larger needed when is used in with ether gallamine conjunction the removal Anti¬ because latter of the impedes drug. COUNCIL ON PHYSICAL MEDICINE dotes should be used with caution in asthmatic patients AND REHABILITATION sensitive such Such adverse antidotal effect is to drugs. also counteracted with atropine. Laboratories co¬ Lederle Division, American Company, Cyanamid The Council on Medicine and Rehabilitation scientific data in the of Physical operated by to aid evaluation gallamine furnishing triethiodide. has authorized the article. of publication following De Ralph E. Forest, M.D., Secretary C17H24N2O.HCI. Dimethisoquin Hydrochloride. —M.W. 308.86.—3-Butyl-l-(2-dimethylaminoethoxy) FEDERAL COMMUNICATIONS COMMISSION structural formula of isoquinoline hydrochloride.—The TYPE APPROVAL FOR MEDICAL

Journal

JAMAAmerican Medical Association

Published: Sep 10, 1955

There are no references for this article.